VANDA PHARMACEUTICALS INC (VNDA) Stock Price, Quote, News and Overview
NASDAQ:VNDA - Nasdaq - US9216591084 - Common Stock - Currency: USD
VNDA Quote, Performance and Key Statistics
VANDA PHARMACEUTICALS INC
NASDAQ:VNDA (2/4/2025, 8:14:40 PM)
After market: 4.48 0 (0%)4.48
+0.17 (+3.94%)
The current stock price of VNDA is 4.48 USD. In the past month the price decreased by -7.63%. In the past year, price increased by 7.69%.
VNDA Latest News, Press Releases and Analysis
Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R Antagonist
/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) and AnaptysBio, Inc. (Anaptys) (Nasdaq: ANAB) today announced an exclusive, global license...
Vanda Pharmaceuticals Accepts FDA Opportunity for a Hearing on New Drug Application for Tradipitant in Gastroparesis
/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today provides an update on the tradipitant development program. Gastroparesis is a serious...
FDA Unveils Grounds For Rejecting Vanda Pharmaceuticals Stomach Paralysis Candidate
FDA denies Vanda's Tradipitant application for gastroparesis, urging new trials for efficacy and safety. Vanda disputes the agency's review process.
Vanda's Letter to FDA Commissioner Highlights Faulty Gastroparesis NDA Review
/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) letter to FDA Commissioner highlights faulty gastroparesis NDA review. As previously...
VNDA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.77 | 335.67B | ||
| AMGN | AMGEN INC | 15.04 | 155.36B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 945.65 | 124.20B | ||
| GILD | GILEAD SCIENCES INC | 22.12 | 122.12B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.60B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.95B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 34.95B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.08B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.76B | ||
| NTRA | NATERA INC | N/A | 23.00B | ||
| BIIB | BIOGEN INC | 8.73 | 20.76B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.52 | 15.78B |
Related stock screener links
About VNDA
Company Profile
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The company is headquartered in Washington, Washington Dc and currently employs 203 full-time employees. The company went IPO on 2006-04-12. The Company’s commercial portfolio is comprised of three products: HETLIOZ for the treatment of non-24-hour sleep-wake disorder (Non-24) and for the treatment of nighttime sleep disturbances in smith-magenis syndrome (SMS), Fanapt (iloperidone) for the treatment of bipolar I disorder and a long acting injectable (LAI) formulation for the treatment of schizophrenia, and PONVORY (ponesimod) for the treatment of inflammatory/autoimmune disorders, including ulcerative colitis, psoriasis, Crohn's disease, atopic dermatitis, eosinophilic esophagitis and alopecia areata. The firm also has a range of drugs in development, including Tradipitant (VLY-686), VHX-896, VSJ-110, VPO-227, VTR-297, VQW-765, VCA-894A and Type 2S (CMT2S).
Company Info
VANDA PHARMACEUTICALS INC
Suite 300E, 2200 Pennsylvania Ave Nw
WASHINGTON WASHINGTON DC 20037 US
CEO: Mihael H. Polymeropoulos
Employees: 203
Company Website: https://www.vandapharma.com/
Investor Relations: https://www.vandapharma.com/investors
Phone: 12027343400
VNDA FAQ
What is the stock price of VNDA?
The current stock price of VNDA is 4.48 USD.
What is the symbol for VANDA PHARMACEUTICALS INC stock?
The exchange symbol of VANDA PHARMACEUTICALS INC is VNDA and it is listed on the Nasdaq exchange.
On which exchange is VNDA stock listed?
VNDA stock is listed on the Nasdaq exchange.
Is VNDA a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for VNDA, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of VNDA.
Does VNDA stock pay dividends?
VNDA does not pay a dividend.
When does VNDA stock report earnings?
VNDA will report earnings on 2025-02-05, after the market close.
What is the Price/Earnings (PE) ratio of VNDA?
VNDA does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.28).
What is the Short Interest ratio of VNDA stock?
The outstanding short interest for VNDA is 5.82% of its float.
VNDA Technical Analysis
VNDA Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to VNDA. VNDA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
VNDA Financial Highlights
Over the last trailing twelve months VNDA reported a non-GAAP Earnings per Share(EPS) of -0.28. The EPS decreased by -233.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.54% | ||
| ROE | -3.03% | ||
| Debt/Equity | 0 |
VNDA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to VNDA. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of -752.8% and a revenue growth 8.16% for VNDA